Washington: Recent research from the University of Missouri school of medicine Suggests Diabetes Drug May Enhance Chemotherapy for Lung Cancer.
Recent research from the University of Missouri School of Medicine indicates that a diabetes medication might make chemotherapy treatments for lung cancer more effective.
In a study published in the journal Clinical Cancer Research by the American Association for Cancer Research, Dr. Yusuf Kaifi explained that researchers have identified a method to make cancer cells more sensitive to chemotherapy.
Dr. Kaifi noted that traditional treatments for lung cancer, including chemotherapy, often have minimal impact due to drug resistance.
This resistance is a major cause of mortality among patients, making it crucial to find ways to counteract drug resistance and improve treatment outcomes.
The study examined tumors from 10 lung cancer patients, half of whom were identified as having resistance to anti-cancer drugs.
Tumors resistant to drugs displayed a specific enzyme, AKR1B10. When treated with the diabetes medication, these tumors showed reduced drug resistance, significantly increasing their sensitivity to chemotherapy and making treatment more effective.